Global Implantable Medical Devices Market

Implantable Medical Devices Market Size, Share, Growth Analysis, By Product(Cardiovascular Implants, Orthopedic Implants, Ophthalmology Implants, Dental Implants), By Biomaterial(Ceramic, Metallic, Polymers, Natural), By End-Use(Hospitals, Outpatient Facilities, Specialty Clinics & Centers), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2510 | Region: Global | Published Date: September, 2024
Pages: 165 | Tables: 130 | Figures: 77

Implantable Medical Devices Market Insights

Implantable Medical Devices Market size was valued at USD 96.11 Billion in 2023 and is poised to grow from USD 102.07 Billion in 2024 to USD 165.15 Billion by 2032, growing at a CAGR of 6.20% during the forecast period (2025-2032).

Devices or tissues that are inserted into or applied to the body's surface are known as implants. For the purpose of replacing lost body components, many implants are prostheses. A few more implants support tissues and organs, monitor physiological processes, or provide medicine. Controlled Permanent implants can be taken out when they are no longer useful, or they might be introduced for therapeutic and monitoring or diagnostic reasons. Adhered joints, on the other hand, have the additional challenge of working under complex and highly demanding conditions of stress, and the end of the devices’ life cycles is ever increasing. On the other hand, elements of long-term implants carry the benefit of being within constant temperature conditions. 

Growing rates of chronic disease along with an ageing population, an increase in neurological and cardiovascular disorders, and advancements in active implanted medical devices are the main factors propelling the growth of the global implantable medical devices market. Further factors supporting the market's expansion include growing investments and funding for the development of technologically sophisticated goods, growing awareness of medical implants and technological developments in those fields, and an increase in the uses of neurostimulators. The medical surgery industry is anticipated to face growth challenges due to high implantation costs and a shortage of skilled personnel. The global implantable medical devices market, on the other hand, is expanding due to the rise in reimbursement schemes.

US Implantable Medical Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Implantable Medical Devices Market size was valued at USD 96.11 Billion in 2023 and is poised to grow from USD 102.07 Billion in 2024 to USD 165.15 Billion by 2032, growing at a CAGR of 6.20% during the forecast period (2025-2032).

The competitive landscape of the global implantable medical devices market is characterized by the presence of key players striving for innovation and market share. The industry is dominated by well-known corporations such as Medtronic, Abbott Laboratories, Boston Scientific, and Johnson & Johnson, which have sophisticated products and technologies. These companies carry out extensive research and development aimed at increasing the effectiveness of its devices and ensuring better health results for patients. Besides, these groups emphasize forming new alliances and taking over other firms to enlarge their product range and presence in developing countries. 'Medtronic Plc (Ireland) ', 'Abbott Laboratories (USA) ', 'Johnson & Johnson (USA) ', 'Boston Scientific Corporation (USA) ', 'Smith & Nephew plc (UK) ', 'Stryker (USA) ', 'Cochlear Limited (Australia) ', 'Integra LifeSciences (USA) ', 'LivaNova PLC (UK) ', 'Biotronik SE and Co. KG (Germany) ', 'Zimmer Biomet Holdings, Inc. (US) ', 'Edwards Lifesciences Corporation (US) ', 'Hearing Life (US) ', 'Nevro Corp. (US) ', 'Orthofix Medical Inc. (US) ', 'NuVasive, Inc. (US) ', 'W. L. Gore & Associates, Inc. (US) ', 'AngioDynamics, Inc. (US) ', 'Ramsay Santé (France) ', 'Hologic, Inc. (US) ', 'Abiomed, Inc. (US) ', 'Straumann Holding AG (Switzerland) ', 'KARL STORZ SE & Co. KG (Germany)'

The rising incidence of chronic diseases, such as cardiovascular conditions, diabetes, and orthopedic disorders, is a significant driver for the global implantable medical devices market. With the increase in elderly population globally, the need for well-advanced therapeutic interventions, implantable devices inclusive, is on the rise fueling market development. 

Integration of Smart Technologies: The global implantable medical devices market is increasingly integrating smart technologies, such as sensors and connectivity features. By incorporating these technologies, it is now possible to monitor healthcare indicators in real time: healthcare personnel can monitor the patient’s parameters from a distance, which contributes to the quality of individualized care and improves the healthcare outcomes through early action and better control of diseases. 

North America dominates the global implantable medical devices market due to several key factors, including advanced healthcare infrastructure, significant investment in research and development, and a high prevalence of chronic diseases. There exists a strong regulatory environment in the region that stimulates creativity and facilitates rapid review processes for new products. Moreover, there is a viable healthcare system and a growing number of elderly people that create a need for implantable devices. Added healthcare costs, together with rising concern by patients about available treatment options and the rise in medical technological innovations, reinforces the stand of the north region as the market leader, creating an avenue for the innovation and use of implantable medical devices. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Implantable Medical Devices Market

Report ID: SQMIG35A2510

$5,300
BUY NOW GET FREE SAMPLE